Your browser doesn't support javascript.
loading
Vpr attenuates antiviral immune responses and is critical for full pathogenicity of SIVmac239 in rhesus macaques.
Laliberté, Alexandre; Prelli Bozzo, Caterina; Stahl-Hennig, Christiane; Hunszinger, Victoria; Joas, Simone; Sauermann, Ulrike; Roshani, Berit; Klippert, Antonina; Daskalaki, Maria; Mätz-Rensing, Kerstin; Stolte-Leeb, Nicole; Tharp, Gregory K; Fuchs, Dietmar; Gupta, Prachi Mehrotra; Silvestri, Guido; Nelson, Sydney A; Parodi, Laura; Giavedoni, Luis; Bosinger, Steven E; Sparrer, Konstantin M J; Kirchhoff, Frank.
Afiliação
  • Laliberté A; Institute of Molecular Virology - Ulm University Medical Center, Meyerhofstraße 1, 89081 Ulm, Germany.
  • Prelli Bozzo C; Institute of Molecular Virology - Ulm University Medical Center, Meyerhofstraße 1, 89081 Ulm, Germany.
  • Stahl-Hennig C; German Primate Center, Kellnerweg 4, 37077 Göttingen, Germany.
  • Hunszinger V; Institute of Molecular Virology - Ulm University Medical Center, Meyerhofstraße 1, 89081 Ulm, Germany.
  • Joas S; Institute of Molecular Virology - Ulm University Medical Center, Meyerhofstraße 1, 89081 Ulm, Germany.
  • Sauermann U; German Primate Center, Kellnerweg 4, 37077 Göttingen, Germany.
  • Roshani B; German Primate Center, Kellnerweg 4, 37077 Göttingen, Germany.
  • Klippert A; German Primate Center, Kellnerweg 4, 37077 Göttingen, Germany.
  • Daskalaki M; German Primate Center, Kellnerweg 4, 37077 Göttingen, Germany.
  • Mätz-Rensing K; German Primate Center, Kellnerweg 4, 37077 Göttingen, Germany.
  • Stolte-Leeb N; German Primate Center, Kellnerweg 4, 37077 Göttingen, Germany.
  • Tharp GK; Emory National Primate Research Center, Emory Vaccine Center and Department of Pathology & Laboratory Medicine, Emory University, Atlanta, GA, USA.
  • Fuchs D; German Primate Center, Kellnerweg 4, 37077 Göttingen, Germany.
  • Gupta PM; Emory National Primate Research Center, Emory Vaccine Center and Department of Pathology & Laboratory Medicine, Emory University, Atlanta, GA, USA.
  • Silvestri G; Emory National Primate Research Center, Emory Vaccine Center and Department of Pathology & Laboratory Medicine, Emory University, Atlanta, GA, USA.
  • Nelson SA; Emory National Primate Research Center, Emory Vaccine Center and Department of Pathology & Laboratory Medicine, Emory University, Atlanta, GA, USA.
  • Parodi L; Host-Pathogen Interactions Program, Southwest National Primate Research Center, Texas Biomedical Research Institute, San Antonio, TX, USA.
  • Giavedoni L; Host-Pathogen Interactions Program, Southwest National Primate Research Center, Texas Biomedical Research Institute, San Antonio, TX, USA.
  • Bosinger SE; Emory National Primate Research Center, Emory Vaccine Center and Department of Pathology & Laboratory Medicine, Emory University, Atlanta, GA, USA.
  • Sparrer KMJ; Institute of Molecular Virology - Ulm University Medical Center, Meyerhofstraße 1, 89081 Ulm, Germany.
  • Kirchhoff F; Institute of Molecular Virology - Ulm University Medical Center, Meyerhofstraße 1, 89081 Ulm, Germany.
iScience ; 26(12): 108351, 2023 Dec 15.
Article em En | MEDLINE | ID: mdl-38025783
ABSTRACT
The accessory viral protein R (Vpr) is encoded by all primate lentiviruses. Vpr counteracts DNA repair pathways, modulates viral immune sensing, and induces cell-cycle arrest in cell culture. However, its impact in vivo is controversial. Here, we show that deletion of vpr is associated with delayed viral replication kinetics, rapid innate immune activation, development and maintenance of strong B and T cell responses, and increased neutralizing activity against SIVmac239 in rhesus macaques. All wild-type SIVmac239-infected animals maintained high viral loads, and five of six developed fatal immunodeficiency during ∼80 weeks of follow-up. Lack of Vpr was associated with better preservation of CD4+ T cells, lower viral loads, and an attenuated clinical course of infection in most animals. Our results show that Vpr contributes to efficient viral immune evasion and the full pathogenic potential of SIVmacin vivo. Inhibition of Vpr may improve humoral immune control of viral replication.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article